Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ENZYBIOTX

Financiado

Cerrado

Upgrading business potential of Enzybiotx

Since the discovery of penicillin people were living in justified confidence that available antibiotics can cure any bacterial infections. Emerging antibiotic resistance was usually overcome by treatment with new generation of ant... ver más

31/01/2023

ENZYBIOTX

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

ENZYBIOTX SPOLKA Z OGRANICZONA ODPOWIEDZIALNO... No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-01-31

HORIZON-EIE-2021-SCALEUP-01-03: Women TechEU ExpectedOutcome:

Innovación

Cerrada hace 3 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ENZYBIOTX

75.00K€ | Lider

Proyectos interesantes

ENABLE

Medical Technol...

Pharmaceutical...

101M€ Cerrado

ENABLE

Medical Technol...

Pharmaceutical...

101M€ Cerrado

NAM

Medical Technol...

Pharmaceutical...

1M€ Cerrado

D_Bug

Medical Technol...

Pharmaceutical...

150K€ Cerrado

PID2019-105512RB-I00

Medical Technol...

Pharmaceutical...

169K€ Cerrado

GNA NOW

Medical Technol...

Pharmaceuticals

22M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 8 meses Fecha Inicio: 2022-05-16
Fecha Fin: 2023-01-31

Líder del proyecto

ENZYBIOTX SPOLKA Z OGRANICZONA ODPOWIEDZIALNO... No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 75K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Since the discovery of penicillin people were living in justified confidence that available antibiotics can cure any bacterial infections. Emerging antibiotic resistance was usually overcome by treatment with new generation of antibiotics, but during last decades bacteria are clearly winning this race. Overuse of antibiotics, particularly in agriculture, and lack of investments in discovery of new antibiotics lead us to situation when increasing number of bacterial infections cannot be cured due to lack of effective remedy. Antibiotic resistance surveillance revealed rising antibiotic resistance around the world. WHO predicts that if no appropriate actions are taken by 2050 antibiotic resistance will be responsible even for 10 mln deaths every year. To address this urgent medical need new antibiotics and alternative methods of combating antibiotic resistant bacteria are needed. One of the new approaches which is getting more and more interests among academic and industrial research groups are enzybiotics, bacteriolytic enzymes that in a very effective and selective way eliminate bacteria, including antibiotic resistant strains, at the same time displaying very low resistance prevalence. Enzybiotx provides a deep-tech platform for tailor made-enzybiotics targeting specific bacteria. Our company has developed the platform for design and generation of new enzybiotcs to target pathogenic bacteria of interest as an answer to the need of alternative antimicrobials development. The company in collaboration with potential clients is able to prepare tailor-made enzybiotics which target pathogens and in collaboration with the client, perform all tests needed to adjust enzyme’s properties to be able to introduce them to the final products. The founders of the company are experienced academics who have gathered unique expertise in isolation and characterisation of new enzybiotics.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores